DE60010934D1 - Medikamente geeignet zur Behandlung von proliferativen Erkrankungen - Google Patents

Medikamente geeignet zur Behandlung von proliferativen Erkrankungen

Info

Publication number
DE60010934D1
DE60010934D1 DE60010934T DE60010934T DE60010934D1 DE 60010934 D1 DE60010934 D1 DE 60010934D1 DE 60010934 T DE60010934 T DE 60010934T DE 60010934 T DE60010934 T DE 60010934T DE 60010934 D1 DE60010934 D1 DE 60010934D1
Authority
DE
Germany
Prior art keywords
treatment
proliferative diseases
medicines suitable
medicines
proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60010934T
Other languages
English (en)
Other versions
DE60010934T2 (de
Inventor
Salim Al-Awar
Andrew Hecker
Jianping Huang
Sajan Joseph
Edward Ray
Parker Waid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE60010934D1 publication Critical patent/DE60010934D1/de
Publication of DE60010934T2 publication Critical patent/DE60010934T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
DE60010934T 1999-12-16 2000-12-18 Medikamente geeignet zur Behandlung von proliferativen Erkrankungen Expired - Fee Related DE60010934T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17126999P 1999-12-16 1999-12-16
US17121999P 1999-12-16 1999-12-16
US171219P 1999-12-16
US171269P 1999-12-16
PCT/US2000/033274 WO2001044235A2 (en) 1999-12-16 2000-12-18 Agents and methods for the treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
DE60010934D1 true DE60010934D1 (de) 2004-06-24
DE60010934T2 DE60010934T2 (de) 2005-05-19

Family

ID=26866852

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60010934T Expired - Fee Related DE60010934T2 (de) 1999-12-16 2000-12-18 Medikamente geeignet zur Behandlung von proliferativen Erkrankungen

Country Status (6)

Country Link
EP (1) EP1250334B1 (de)
AT (1) ATE267194T1 (de)
AU (1) AU2576901A (de)
DE (1) DE60010934T2 (de)
ES (1) ES2220585T3 (de)
WO (1) WO2001044235A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215325B8 (en) 2002-03-05 2008-10-09 Eli Lilly And Company Purine derivatives as kinase inhibitors
AU2003217596A1 (en) 2002-03-08 2003-09-22 Eli Lilly And Company Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors
SI1846406T1 (sl) 2005-02-09 2011-02-28 Arqule Inc Maleimidni derivati, farmacevtski sestavki in postopki za zdravljenje raka
MX2009013815A (es) 2007-06-22 2010-03-01 Arqule Inc Compuestos de quinazolinona y metodos de uso para los mismos.
WO2009002807A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Indolyl pyrrolidines for the treatment of cancer
WO2009002806A1 (en) * 2007-06-22 2008-12-31 Arqule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
US8563567B2 (en) 2009-12-30 2013-10-22 Arqule, Inc. Substituted heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1339895A (en) * 1993-12-23 1995-07-10 Eli Lilly And Company Protein kinase c inhibitors
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos

Also Published As

Publication number Publication date
AU2576901A (en) 2001-06-25
ATE267194T1 (de) 2004-06-15
DE60010934T2 (de) 2005-05-19
ES2220585T3 (es) 2004-12-16
WO2001044235A3 (en) 2002-01-17
EP1250334B1 (de) 2004-05-19
EP1250334A2 (de) 2002-10-23
WO2001044235A2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
ATE408601T1 (de) Fredericamycin-derivate
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE323474T1 (de) Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE266031T1 (de) Verfahren und verbindungen zur behandlung proliferativer erkrankungen
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
ATE265455T1 (de) Tetrahydropyridoverbindungen
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
MXPA04005809A (es) Inhibidores de proteinas quinasas.
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee